CompoundingGain

First Oral approved favipiravir medication for COVID

看多
NSE:GLENMARK   GLENMARK PHARM


Sitting just under resistance at 421 expect this to be taken out on open and the retest IF it happens is a good spot to load up.

Recon this should fly to 574 then get knocked back a bit for a while before flying up with more power .

Might be wrong and the FOMO on this may keep blasting it up , the downtrend line is not that far off so all indicators should turn into buy once that is taken out .

Lets see ..

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。